American International Group’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-50,173
| Closed | -$19.8K | – | 2856 |
|
|
2024
Q1 | $19.8K | Sell |
50,173
-9
| -0% | -$4 | ﹤0.01% | 2932 |
|
|
2023
Q4 | $785K | Sell |
50,182
-5
| -0% | -$78 | ﹤0.01% | 1430 |
|
|
2023
Q3 | $2.48M | Buy |
50,187
+228
| +0.5% | +$11.3K | 0.02% | 893 |
|
|
2023
Q2 | $3.91M | Buy |
49,959
+225
| +0.5% | +$17.6K | 0.02% | 806 |
|
|
2023
Q1 | $4.51M | Buy |
49,734
+13
| +0% | +$1.18K | 0.03% | 763 |
|
|
2022
Q4 | $5.87M | Sell |
49,721
-2
| -0% | -$236 | 0.04% | 634 |
|
|
2022
Q3 | $9.02M | Buy |
49,723
+9
| +0% | +$1.63K | 0.07% | 366 |
|
|
2022
Q2 | $4.46M | Sell |
49,714
-5
| -0% | -$449 | 0.03% | 743 |
|
|
2022
Q1 | $7.72M | Sell |
49,719
-45
| -0.1% | -$6.99K | 0.04% | 593 |
|
|
2021
Q4 | $14.8M | Sell |
49,764
-20
| -0% | -$5.95K | 0.07% | 286 |
|
|
2021
Q3 | $28.7M | Buy |
49,784
+6,070
| +14% | +$3.5M | 0.15% | 102 |
|
|
2021
Q2 | $19.8K | Sell |
43,714
-31
| -0.1% | -$14 | 0.07% | 229 |
|
|
2021
Q1 | $23.5K | Buy |
43,745
+4,162
| +11% | +$2.24K | 0.08% | 178 |
|
|
2020
Q4 | $35K | Buy |
39,583
+39,117
| +8,394% | +$34.6K | 0.13% | 120 |
|
|
2020
Q3 | $295K | Buy |
+466
| New | +$295K | ﹤0.01% | 1897 |
|